Abstract
The ability of several, live type A influenza viruses to enhance the serum haemagglutination-inhibiting (HI) antibody response of hamsters to subsequent immunization with inactivated, heterotypic influenza virus vaccines was examined. Live influenza viruses were found to vary in their priming ability for a given vaccine, and a given virus was not able to prime for all inactivated vaccines to an equal extent. Common determinants in the haemagglutinin antigens of the priming virus and the vaccine virus were suggested as responsible for the enhancement of the antibody response to some of the vaccines, but for other pairs of viruses the haemagglutinin antigens were distinct. Thus, enhancement in these instances cannot be due to cross-reacting haemagglutinins. Pre-infection of hamsters by several influenza type A viruses was employed in an attempt to enhance the serum HI antibody response to purified, haemagglutinin antigens prepared from A/PR/8/34 and the MRC-2 recombinant strain of A/England/42/72 viruses. Although prior infection enhanced the antibody response to whole virus, this was not demonstrable for the purified haemagglutinin components of the virus. The possible reasons for this are discussed.
Article PDF
Similar content being viewed by others
References
Brand, C. M., Skehel, J. J.: Crystalline antigen from the influenza virus envelope. Nature New Biol.238, 145–147 (1972)
Coleman, M., Dowdle, W. R., Pereira, H. G., Schild, G. C., Chang, W. K.: The Hong Kong/68 influenza A2 variant. Lancet1968II, 1384–1386
Dowdle, W. R., Marine, W. M., Coleman, M., Knez, V.: Haemagglutinin relationships of Hong Kong (H3) and Asian (H2) influenza strains delineated by antigen-specific recombinants. J. Gen. Virol.16, 127–134 (1972)
Friedewald, W. F., Hook, E. W., Jr.: Influenza virus infections in the hamster. A study of inapparent virus infection and virus adaptation. J. exp. Med.88, 343–353 (1948)
Jennings, R., Potter, C. W.: Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection. Arch. ges. Virusforsch.42, 197–206 (1973)
Jennings, R., Potter, C. W., McLaren, C.: Effect of pre-infection and pre-immunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines. J. Immunol. (in press, 1974)
Katz, D. H., Paul, W. E., Goidl, E. A., Benacerraf, B.: Carrier function in antihapten immune responses. 1. Enhancement of primary and secondary antihapten antibody responses by carrier preimmunization. J. exp. Med.132, 261–282 (1970)
Marine, W. M., Workman, W. M., Webster, R. G.: Immunological interrelationship of Hong Kong, Asian and Equi-2 influenza viruses in man. Bull. Wld Hlth Org.41, 475–482 (1969)
Potter, C. W., Jennings, R., McLaren, C., Marine, W. M.: The potentiation of the antibody response to inactivated A2/Hong Kong vaccines by previous heterotypic influenza virus infection. Microbios8, 101–110 (1973)
Potter, C. W., Jennings, R., Rees, R. C., McLaren, C.: Antibody response of hamsters to A2/Hong Kong virus vaccine after priming by heterotypic virus infection. Infect. Immun.8, 137–144 (1973a)
Schild, G. C., Henry-Aymard, M., Pereira, H. G.: A quantitative single-radial-diffusion test for immunllogical studies with influenza virus. J. gen. Virol.16, 231–236 (1972)
Skehel, J. J., Schild, G. C.: The polypeptide composition of influenza A viruses. Virology44, 396–408 (1971)
Tumova, B., Easterday, B. C.: Relationship of envelope antigens of animal influenza viruses to human A2 influenza strains isolated in the years 1957–68. Bull. Wld Hlth Org.41, 429–435 (1969)
Webster, R. G., Laver, W. G.: Studies on the origin of pandemic influenza. 1. Antigenic analysis of A2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated haemagglutinin subnuits. Virology48, 433–444 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jennings, R., Brand, C.M., McLaren, C. et al. The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection. Med Microbiol Immunol 160, 295–309 (1974). https://doi.org/10.1007/BF02121445
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02121445